#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uterine leiomyosarcoma Small cell lung cancer limited stage Follicle centre lymphoma follicular grade I, II – III Pyruvate dehydrogenase complex deficiency Frontotemporal dementia Cervix carcinoma recurrent Progressive supranuclear palsy Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Cholestatic pruritus Congenital cystic kidney disease Adenocarcinoma pancreas Antiphospholipid syndrome Hidradenitis Anal squamous cell carcinoma Hypomagnesaemia More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Diagnostics Systemic mastocytosis – Treatment Leiomyosarcoma – Basic Information Gastrointestinal stromal tumour – Trials in Disease Mastocytosis – Life with Disease Usher’s syndrome – Trials in Disease Mucopolysaccharidosis III – Basic Information Immunodeficiency congenital Primary biliary cholangitis – Treatment Hereditary optic atrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Povorcitinib XELAFASLATIDE Ribonucleic Acid Lutetium (177Lu) Oxodotreotide Gallium (68Ga) Gozetotide Psma-11 Glucose Monohydrate VIPOGLANSTAT Interferon Gamma Anhydrous Benzoyl Peroxide 177LU-PSMA-I&T Pimozide Ferric Carboxymaltose Octocog Alfa Mometasone SODIUM FUSIDATE Copper (64Cu) Chloride Orlistat Haloperidol Paracetamol Ph. Eur. More therapies…

    Learn about Your Condition

    Milk allergy Thalassaemia alpha Small intestine adenocarcinoma Developmental hip dysplasia Eructation Ocular myasthenia Altered state of consciousness Haemodialysis Psychological trauma Injury Polycystic liver disease Cystic fibrosis lung Penile squamous cell carcinoma Peritoneal dialysis Thalassaemia beta More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Breslauer Strasse 201, Langwasser, Nürnberg, 90471, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Amylase, Protease, and Rizolipase for Patients After Gastrectomy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Amylase
    • Protease
    • Rizolipase
    Germany

  • Study on the Safety and Effectiveness of IMA402, Tocilizumab, and Human Serum Albumin for Patients with Recurrent or Resistant Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Decitabine
    • Human Serum Albumin
    • Ima402
    Germany The Netherlands

  • Study on Treatment Options for Patients with Oligometastatic Pancreatic Cancer: Comparing Oxaliplatin, Fluorouracil, Folinic Acid, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    Finland Germany The Netherlands Sweden

  • Study Comparing Venetoclax and Azacitidine with Standard Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients with NPM1 Mutations Eligible for Intensive Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Cytarabine
    • Daunorubicin Hydrochloride
    Germany

  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Carfilzomib
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +11

  • Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Elacestrant
    • Exemestane
    Belgium Cyprus France Germany Greece Ireland +5

  • Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Nivolumab
    • Relatlimab
    Austria Belgium Czechia Finland France Germany +5

  • Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Durvalumab
    • Enfortumab Vedotin
    France Germany Italy Poland Spain

  • A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone
    Denmark France Germany Italy Poland Spain +1
Previous Page
1 … 3 4 5 6 7 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!